Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Christopher Jonathan Britten Insider Profile

4 Followers

Christopher Jonathan Britten, Director at N4 Pharma, holds ― shares in N4 Pharma (Ticker: GB:THAT). Most recently, Christopher Jonathan Britten Bought 1,666,666 shares of N4 Pharma on Jun 24, 2026 for an estimated value of 10.00K .

Christopher Jonathan Britten's Trading History

THATN4 Pharma		Jun 24, 2026DirectorInformative Buy10.00K―
GB:THAT
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 24, 2026Informative Buy£10.00K1,666,666£1.00――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Christopher Jonathan Britten insider profile FAQ

What stocks does Christopher Jonathan Britten hold?
Christopher Jonathan Britten holds: GB:THAT stocks.
What was Christopher Jonathan Britten’s latest transaction?
Christopher Jonathan Britten’s latest transaction was an Informative Buy of 10.00K .
What is Christopher Jonathan Britten's role in N4 Pharma?
Christopher Jonathan Britten's role in N4 Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.